Literature DB >> 12390302

Highly active antiretroviral therapy and beta-chemokines.

B Brichacek, M Bukrinsky.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12390302      PMCID： PMC1906529          DOI： 10.1046/j.1365-2249.2002.02010.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

1.  Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

Authors:  A Garzino-Demo; R B Moss; J B Margolick; F Cleghorn; A Sill; W A Blattner; F Cocchi; D J Carlo; A L DeVico; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

Authors:  F Cocchi; A L DeVico; R Yarchoan; R Redfield; F Cleghorn; W A Blattner; A Garzino-Demo; S Colombini-Hatch; D Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Authors:  M Plana; F García; T Gallart; C Tortajada; A Soriano; E Palou; M J Maleno; J J Barceló; C Vidal; A Cruceta; J M Miró; J M Gatell
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

5.  CCR5 and beta-chemokines in HIV-1 infected children.

Authors:  E Sanchez-Carrasquillo; V García; C E Rivera; I Febo; L M Melendez-Guerrero
Journal:  P R Health Sci J       Date:  2000-12       Impact factor: 0.705

6.  CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.

Authors:  A Giovannetti; F Ensoli; F Mazzetta; M De Cristofaro; M Pierdominici; D S Muratori; V Fiorelli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.

Authors:  J Blanco; C Cabrera; A Jou; L Ruiz; B Clotet; J A Esté
Journal:  AIDS       Date:  1999-04-01       Impact factor: 4.177

8.  RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication.

Authors:  S Fransen; K F Copeland; M Smieja; F Smaill; K L Rosenthal
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.

Authors:  L M Carter; B S Peters; B A Ellis; R A Wolstencroft
Journal:  J Infect       Date:  2000-11       Impact factor: 6.072

10.  Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta.

Authors:  D Kumar; K Parato; A Kumar; E Sun; D W Cameron; J B Angel
Journal:  AIDS Res Hum Retroviruses       Date:  1999-08-10       Impact factor: 2.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.